These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Emerging biomarkers and screening for cognitive frailty. Ruan Q; D'Onofrio G; Sancarlo D; Greco A; Lozupone M; Seripa D; Panza F; Yu Z Aging Clin Exp Res; 2017 Dec; 29(6):1075-1086. PubMed ID: 28260159 [TBL] [Abstract][Full Text] [Related]
4. Different Cognitive Frailty Models and Health- and Cognitive-related Outcomes in Older Age: From Epidemiology to Prevention. Panza F; Lozupone M; Solfrizzi V; Sardone R; Dibello V; Di Lena L; D'Urso F; Stallone R; Petruzzi M; Giannelli G; Quaranta N; Bellomo A; Greco A; Daniele A; Seripa D; Logroscino G J Alzheimers Dis; 2018; 62(3):993-1012. PubMed ID: 29562543 [TBL] [Abstract][Full Text] [Related]
5. Time to test antibacterial therapy in Alzheimer's disease. Panza F; Lozupone M; Solfrizzi V; Watling M; Imbimbo BP Brain; 2019 Oct; 142(10):2905-2929. PubMed ID: 31532495 [TBL] [Abstract][Full Text] [Related]
7. Targeting Cognitive Frailty: Clinical and Neurobiological Roadmap for a Single Complex Phenotype. Panza F; Seripa D; Solfrizzi V; Tortelli R; Greco A; Pilotto A; Logroscino G J Alzheimers Dis; 2015; 47(4):793-813. PubMed ID: 26401761 [TBL] [Abstract][Full Text] [Related]
8. Cognitive Frailty: A Systematic Review of Epidemiological and Neurobiological Evidence of an Age-Related Clinical Condition. Panza F; Solfrizzi V; Barulli MR; Santamato A; Seripa D; Pilotto A; Logroscino G Rejuvenation Res; 2015 Oct; 18(5):389-412. PubMed ID: 25808052 [TBL] [Abstract][Full Text] [Related]
9. Sensorial frailty: age-related hearing loss and the risk of cognitive impairment and dementia in later life. Panza F; Lozupone M; Sardone R; Battista P; Piccininni M; Dibello V; La Montagna M; Stallone R; Venezia P; Liguori A; Giannelli G; Bellomo A; Greco A; Daniele A; Seripa D; Quaranta N; Logroscino G Ther Adv Chronic Dis; 2019; 10():2040622318811000. PubMed ID: 31452865 [TBL] [Abstract][Full Text] [Related]
10. Gut microbiota, cognitive frailty and dementia in older individuals: a systematic review. Ticinesi A; Tana C; Nouvenne A; Prati B; Lauretani F; Meschi T Clin Interv Aging; 2018; 13():1497-1511. PubMed ID: 30214170 [TBL] [Abstract][Full Text] [Related]
11. Associations of a biopsychosocial frailty phenotype with all-cause dementia, Alzheimer's disease, vascular dementia, and other dementias: the Italian PRoject on the Epidemiology of Alzheimer's disease (IPREA). Scafato E; Solfrizzi V; Custodero C; Casieri G; Falco C; Maggipinto R; Gandin C; Galluzzo L; Ghirini S; Matone A; Dibello V; Sardone R; Daniele A; Lozupone M; Panza F; Geroscience; 2023 Jun; 45(3):2037-2049. PubMed ID: 37014539 [TBL] [Abstract][Full Text] [Related]
12. Treatment of Porphyromonas gulae infection and downstream pathology in the aged dog by lysine-gingipain inhibitor COR388. Arastu-Kapur S; Nguyen M; Raha D; Ermini F; Haditsch U; Araujo J; De Lannoy IAM; Ryder MI; Dominy SS; Lynch C; Holsinger LJ Pharmacol Res Perspect; 2020 Feb; 8(1):e00562. PubMed ID: 31999052 [TBL] [Abstract][Full Text] [Related]
13. Biopsychosocial frailty and mild cognitive impairment subtypes: Findings from the Italian project on the epidemiology of Alzheimer's disease (IPREA). Solfrizzi V; Scafato E; Custodero C; Piazzolla G; Capogna L; Procaccio A; Gandin C; Galluzzo L; Ghirini S; Matone A; Dibello V; Sardone R; Daniele A; Lozupone M; Panza F; Alzheimers Dement; 2023 Aug; 19(8):3306-3315. PubMed ID: 36757048 [TBL] [Abstract][Full Text] [Related]
14. Towards a Redefinition of Cognitive Frailty. Mantovani E; Zucchella C; Schena F; Romanelli MG; Venturelli M; Tamburin S J Alzheimers Dis; 2020; 76(3):831-843. PubMed ID: 32568197 [TBL] [Abstract][Full Text] [Related]
15. A Possible Association Between Executive Dysfunction and Frailty in Patients With Neurocognitive Disorders. Bartoli M; Palermo S; Cipriani GE; Amanzio M Front Psychol; 2020; 11():554307. PubMed ID: 33262722 [TBL] [Abstract][Full Text] [Related]
16. Female dominant association of sarcopenia and physical frailty in mild cognitive impairment and Alzheimer's disease. Ohta Y; Nomura E; Hatanaka N; Osakada Y; Matsumoto N; Sasaki R; Tsunoda K; Takemoto M; Tadokoro K; Hishikawa N; Wakutani Y; Yamashita T; Sato K; Omote Y; Abe K J Clin Neurosci; 2019 Dec; 70():96-101. PubMed ID: 31444048 [TBL] [Abstract][Full Text] [Related]
17. Souvenaid for Alzheimer's disease. Burckhardt M; Watzke S; Wienke A; Langer G; Fink A Cochrane Database Syst Rev; 2020 Dec; 12(12):CD011679. PubMed ID: 33320335 [TBL] [Abstract][Full Text] [Related]
18. Relationships of Fall Risk With Frailty, Sarcopenia, and Balance Disturbances in Mild-to-Moderate Alzheimer's Disease. Güner Oytun M; Topuz S; Baş AO; Çöteli S; Kahyaoğlu Z; Boğa İ; Ceylan S; Doğu BB; Cankurtaran M; Halil M J Clin Neurol; 2023 May; 19(3):251-259. PubMed ID: 36647232 [TBL] [Abstract][Full Text] [Related]